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AmikacinAltogether, 98 Pseudomonas aeruginosa isolates from a 5-bed intensive care unit were ﬁngerprinted with
pulsed-ﬁeld gel electrophoresis and tested for aminoglycoside resistance genes aac(6′)-Ib, aac(3″)-IIa, ant(2″)-
Ia, armA, rmtA, and rmtB and integrons and virulence genes/operons phzI, phzII, phzM, phzS, apr, lasB, plcH, plcN,
pilA, algD, toxA, exoS, exoT, exoY, and exoU. Twomajor clusters were identiﬁed (49 and 19 isolates), harbouring
aac(6′)-Ib, blaPSE-1, and ant(3″)-Ia genes or ant(2″)-Ia gene, respectively, on a class I integron. Most virulence
genes except for exoU and pilA were found. Only 1 isolate of the minor cluster (8 isolates) and 1 of the 22
sporadic isolates carried integrons (without gene cassettes); virulence proﬁle was highly variable. Comparing
the resistance and virulence patterns of endemic and sporadic isolates suggests that integron-borne
aminoglycoside resistance is more closely associated with the frequency than virulence. Consequently,
aminoglycoside usage may have played a role in maintenance of the endemic clones.36-52-255-424.
lsevier Inc.
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Healthcare–associated infections represent the most serious
problem of present-day medicine. Pseudomonas aeruginosa is a
signiﬁcant pathogen in such infections considering its natural
resistance to many antimicrobials and its predisposition for acquired
resistance as well (Navon-Venezia et al., 2005). It causes the most
severe problems in intensive care units (ICUs), especially among
mechanically ventilated patients, where it is among the ﬁrst
pathogens colonizing the respiratory tract (Navon-Venezia et al.,
2005). Accordingly, ventilator-associated pneumonia (VAP) is fre-
quently caused by P. aeruginosa. Moreover, increased mortality was
shown even in patients not meeting the criteria for VAP, but with high
burden of P. aeruginosa in the airways (Zhuo et al., 2008).
While outbreaks of multiresistant P. aeruginosa cause signiﬁcant
morbidity and mortality together with increased healthcare-associ-
ated cost and are therefore readily investigated and reported, the
driving forces behind an endemic pattern are less well studied
(Deplano et al., 2005; Navon-Venezia et al., 2005; Sader et al., 1993).
Hypothetically, the selective advantage of a pathogen in a certain




86Antibiotic usage frequently serves as a driving force both in
outbreaks and in endemicity; outbreaks of multiresistant P.
aeruginosa occurred multiple times as a consequence of antibiotic
overuse. For example, outbreaks of carbapenem- or ceftazidime-
resistant strains associated with carbapenem or third generation
cephalosporin use have been reported several times (e.g., El Amari
et al., 2001; Hsueh et al., 2005). Though the consequences of the
selective pressure exerted by other antibiotic groups are less well
documented, they may be important, especially the frequently used
ﬂuoroquinolones and aminoglycosides. This is especially plausible in
case of aminoglycosides, where resistance is frequently associated
with resistance integrons, genetic structures which were shown to
be associated with nosocomial P. aeruginosa strains (Ruiz-Martínez
et al., 2011).
Despite a number of virulence factors described, the virulence
mechanisms underlying the high mortality of VAP caused by P.
aeruginosa are poorly understood. Type 3 secretion system and its
effectors, especially the exotoxins exoS and exoU, may be important,
but the role of other virulence-associated genes is less unequivocal
(Berra et al., 2010).
The present work is concerned with the ecology of P.
aeruginosa in a non-outbreak situation, i.e., to ﬁnd and describe
differences between successful clones and sporadic isolates in
terms of carriage of virulence factors, aminoglycoside resistance
genes, and integron-associated gene cassettes at a 5-bed ICU with


























































































2 J. Mózes et al. / Diagnostic Microbiology and Infectious Disease xxx (2013) xxx–xxx2. Materials and methods
2.1. Setting of ICU
The ICU involved is a newly constructed 5-bed ICU in a building
previously also dedicated to healthcare. The ICU is directly connected to
the pulmonology clinic of a tertiary care center (university clinic);
therefore, the most common admission diagnosis is respiratory failure
or pneumonia; the most common underlying disease is end-stage
chronic obstructive pulmonary disease (COPD) or lung cancer. The
patient population of the ICU is the elderly in general, as suggested by
the underlying diseases. The ICU also accepts patients directly from
other departments (surgery, internal medicine, etc.) if they are
diagnosed with a pulmonology-related illness. Pediatric patients are
never admitted to the department.
The study was conducted between September 2008 and February
2010 (546 days); during this period, the occupancy index was 85.6%,
and the average ICU stay was 16 (8–33) days. The microbiological
monitoring was intensive; critically ill (e.g., intubated) patients were
sampled frequently; even daily sampling was performed in some cases.
Besides P. aeruginosa, Acinetobacter baumannii, ESBL-producing, and
ESBL-negative Klebsiella pneumoniaewere the most frequently isolated
bacteria. Fungal colonizationwas also frequent, commonlywithCandida
glabrata. Unexpected increases in the number of P. aeruginosa isolations
were not detected. Environmental samples (samples from suckers,









BGn F 1923 ICU 1 Died Respiratory
BI M 1936 ICU 2 Died COPD
BM F 1962 ICU 1 Died COPD
BG M 1951 ICU 1 Died Lung cance
CsI M 1937 Pulmonology 1 Survived COPD
DA M 1960 ICU 1 Survived Pneumonia
DSn F 1928 Pulmonology 1 Survived Pneumonia
DnHI F 1934 ICU 1 Died Pneumonia
DY M 1943 ICU, rehabilitation 1 Survived COPD
JGn F 1928 ICU 1 Survived COPD
KIB M 1926 ICU 7 Died Respiratory
FÁ M 1928 Pulmonology, ICU 1 Survived COPD
FJ M 1969 Pulmonology 1 Survived Pneumonia
HJ M 1947 Oncology 2 Survived Lung cance
IJ M 1950 Pulmonology 2 Died Tuberculos
JSn F 1920 ICU 1 Died Respiratory
KMn F 1939 ICU 1 Died Respiratory
KG M 1950 ICU 1 Survived COPD
KI M 1942 ICU 7 Survived COPD
KJ M 1944 Pulmonology 1 Survived COPD
MM M 1969 ICU 1 Died Respiratory
MJ M 1990 ICU 1 Survived COPD
MF M 1953 Rehabilitation 1 Survived COPD
MZ M 1947 ICU 1 Died Lung cance
MB M 1946 ICU 1 Survived COPD
NGy M 1932 ICU 3 Died Lung cance
NI M 1938 ICU 6 Survived COPD
Oz F 1939 ICU 1 Died COPD
PSn F 1944 Oncology 2 Survived COPD
PJn F 1942 ICU 1 Survived COPD
PL M 1941 ICU 10 Survived COPD
SLn F 1942 ICU 1 Survived Respiratory
SF M 1948 ICU 1 Died COPD
SzS M 1957 ICU 5 died COPD
SzG M 1944 ICU 3 Survived COPD
TJ M 1940 ICU 1 Survived COPD
VFn F 1940 Endoscopy 1 Survived Pneumonia
F = female; M = male.
a These patients only harboured P. aeruginosa isolates belonging to smaller clusters of wi
b Inhalational use.
Please cite this article as: Mózes J, et al, A potential role of aminoglyc
strains in lower airways of mechanic..., Diagn Microbiol Infect Dis (201and tap water samples collected each month during the study period
consistently yielded no Gram-negative bacteria.
2.2. Collection of bacterial isolates
Altogether, 98 isolates of P. aeruginosawere included isolated from
37 patients; patient characteristics are shown in Table 1. The majority
(87) of isolates originated from the ICU from 28 patients; however, 11
isolates of 11 patients from other wards of the clinic (oncology,
pulmonology, and rehabilitation) were also tested. Two patients were
sampled both in the ICU and in other wards. Most isolates were
cultured from lower airway samples (bronchial washing, sputum, or
tracheal aspirate); colony-forming unit (CFU) numbers varied
between 102 and N105/mL. Three samples originated from the upper
airways, 3 from intravenous cannula and 1 from pleural ﬂuid.
Antibiotic susceptibility was determined by the CLSI disk diffusion
method against imipenem, meropenem, piperacillin + tazobactam,
ceftazidime, cefepime, ciproﬂoxacin, amikacin, gentamicin, and
tobramycin. Species identiﬁcation was conﬁrmed by PCR speciﬁc for
P. aeruginosa (Spilker et al., 2004).
2.3. Determination of genotype
Pulsed-ﬁeld gel electrophoresis (PFGE) was used to assess genetic
relatedness. Approximately 4 × 108 CFU of bacteria was gently mixed
with 2% low melting point SeaPlaque agarose (Lonza) containing 1%osis Cumulative dose of aminoglycosides
(cumulative number of DDDs administered)
Clusters
encountered
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3J. Mózes et al. / Diagnostic Microbiology and Infectious Disease xxx (2013) xxx–xxxsodium-lauril-sarcosil and 1 mg/mL Proteinase K (Fermentas). Plugs
were incubated overnight in 100 mmol/L EDTA containing 0.2%
sodium deoxycholate, 1% sodium lauril-sarcosil-sulphate and 1 mg/
mL Proteinase K. On the following day, they were washed for 15
minutes with distilled water, then for 1 hour with Tris-EDTA buffer
containing 0.35 mg/mL PMSF, and ﬁnally 3 times for 1 hour with Tris-
EDTA buffer. Plugs were stored in Tris-EDTA at 4 °C. Before digestion
with restriction enzyme, plugs were washed for 1 hour in the buffer
recommended by the manufacturer. Digestion of plugs was per-
formed with the enzyme SpeI using the buffer and conditions
recommended by the manufacturer. Separation of fragments was
performed in a CHEF DRIII machine (BioRad), in 1% SeaKem Gold
agarose (Lonza) at 14 °C. The gel ran at 6 V/cm, with a reorientation
angle of 120°, switch times were ramped between 5 s and 30 s for 15
hours followed by a 30 to 90 s ramping for 7 hours. Gels were stained
with ethidium bromide and visualized under UV light. DNA banding
patterns were analysed with the Fingerprinting II software (BioRad),
using the Dice coefﬁcient and the UPGMA method with an
optimization of 0.5% and a position tolerance of 1–1.5%. Similarity of
at least 80% was considered as the threshold of probable genetic
relatedness to deﬁne clusters.
Isolates belonging to the same cluster were isolated from a patient
at the ICU and later in another ward were considered to represent an
exportation event. Conversely, importation is deﬁnedwhen a non-ICU
isolate precedes a related isolate found in the ICU.
2.4. Aminoglycoside resistance and integron analysis
DNA was extracted by heat treatment; a loopful of bacteria was
heated to 98 °C in TE buffer (100mmol/L Tris, 10mmol/L EDTA) for 15
minutes, and the supernatant was used as a template. Aminoglycoside
modifying enzyme genes aac(6′)-Ib, ant(2″)-Ia and aac(3)-IIa were
sought for using the methods described by Frana et al. (2001).
Presence of armA, rmtA, and rmtB genes coding for aminoglycoside
resistance methylases was tested using the PCR assays reported by
Bogaerts et al. (2007). Integron carriage was assessed by the PCR
assays of Mazel et al. (2000). Ampliﬁcation and sequencing of the
variable regions were performed for all integron-carrying isolates
outside the clusters as well as for selected isolates representing the
main PFGE clusters as described by White et al. (2001). Sequences
were handled using CLC DNA Workbench 4.0 (CLC Bio), and genes
were identiﬁed by a GenBank search. After restriction site identiﬁca-
tion, the identity of integrons within clusters A and B was conﬁrmed
by restriction fragment length polymorphism analysis of the variable
regions using XbaI and XhoI (Fermentas), respectively, as recom-
mended by the manufacturer.
2.5. Detection of virulence genes.
The genes of virulence factors exotoxin A (toxA), alginate (algD),
type 3 secretion system effectors (exoT, exoS, exoU, exoY), phospholi-
pases (plcH, plcN), proteases (apr, lasB), type IV pili (pilA), phenazin
synthesis (phzI, phzII, phzS, phzM), and pyoverdin receptors (fpvA-I,
fpvA-II, fpvA-III) were sought for by means of previously published PCR
assays (de Chial et al., 2003; Finnan et al., 2004; Lanotte et al., 2004).
2.6. Antibiotic consumption.
Consumption of antibiotics (ﬂuoroquinolones as a group, strepto-
mycin, amikacin, gentamicin, and tobramycin) was expressed in the
number of deﬁned daily doses (DDDs) per 100 bed-days each year
from 2005 to 2009 using the MS Excel application ABC Calc version
3.1. (Monnet 2006). Data on antibiotics used to treat individual
patients were collected from the patient records and expressed in
number of DDDs used. Cumulative administered aminoglycoside
doses per patient are shown in Table 1. Patients were also groupedPlease cite this article as: Mózes J, et al, A potential role of aminoglyc
strains in lower airways of mechanic..., Diagn Microbiol Infect Dis (201according to the genotype of P. aeruginosa harboured (clusters versus
isolates outside the main clusters), and the differences in total
consumption of antibiotics as well as in aminoglycoside consumption
between these groups were analysed by Kruskal-Wallis test and post-
hoc pairwise comparisons with Bonferroni correction using the Past
3.0 software (Hammer et al., 2001). The patient with multidrug-
resistant tuberculosis (IJ) receiving prolonged treatment with
amikacin and streptomycin was excluded from the statistical analysis.
3. Results
3.1. Aminoglycoside resistance and type of integrons
Out of the 6 aminoglycoside resistance genes sought, only the
modifying enzyme genes aac(6′)-Ib and ant(2″)-Ia were found in the
isolates (see below); aac(3′)-IIa, armA, rmtA, and rmtB genes were
never detected. Only class I integrons were detected.
3.2. Genetic relatedness
Among the 98 isolates tested, 3 main similarity clusters (A-C) were
identiﬁed; 22 further isolates belonged to 3 smaller clusters (2–3
isolates) or had unique patterns (Fig. 1.) Cluster A included 49 isolates
from 12 patients; this clusterwas present throughout almost the whole
study period.Multiple patients carried the strain simultaneously during
certain periods, and returning patients were found colonized at
multiple hospitalization events. One isolate was isolated at the
rehabilitation ward from a former ICU patient indicating exportation.
Antibiotic susceptibility of the isolates within the cluster was
highly variable. While all isolates were uniformly resistant to
ciproﬂoxacin, amikacin, gentamicin, and tobramycin, resistance to
other agents was different sometimes even in case of isolates found in
the same day, ranging from susceptibility to all beta-lactam agents
tested to extensive resistance leaving colistine as the only therapeutic
option. All isolates harboured a class I integron with a gene cassette
array aac(6′)-Ib, blaPSE-1, and ant(3′)-Ia (In99 according to the
integron nomenclature at the Integrall database, http://integrall.bio.
ua.pt). The cluster was characterized by presence of ferripyoverdin
receptor type III and lack of pilA and exoU genes; all other virulence
genes were found.
Cluster B included 16 isolates and was present throughout the
study period. Though 9 isolates from a single patient dominated this
cluster, it affected 11 patients altogether. Antibiotic susceptibility was
characterized by ciproﬂoxacin, gentamicin, and tobramycin resis-
tance, but resistance to beta-lactams was less extended as compared
to cluster A; only 5 isolates were resistant to a beta-lactam agent,
resistance to all antipseudomonal beta-lactams was not observed.
These isolates also carried a class I integron harbouring a single
ant(2″)-Ia gene (In159). Virulence gene composition was similar to
that of cluster A, except for the presence of ferripyoverdin receptor
type I instead of type III. Three further isolates were highly similar to
this cluster, showing the same virulence proﬁle and carrying the same
integron (Fig. 1).
Cluster C included 8 isolates and was present at the ICU from
March to December 2009 affecting 6 patients. One isolate (July 2009)
was isolated from a patient in the pulmonology ward (potential
importation/exportation). Antibiotic susceptibility of the cluster was
characterized by imipenem resistance observed in all isolates, except
the pulmonologyward isolate. Besides imipenem resistance, 3 isolates
(from the same patient) showed a somewhat variable resistance to
beta-lactams, ciproﬂoxacin, and aminoglycosides (Fig. 1). One of these
isolates carried class I integrons carrying no gene cassettes (In0).
Curiously, another isolate harboured an aac(6′)-Ib gene; other
aminoglycoside resistance genes were not detected in the cluster.
Except exoS, all virulence genes sought for were present.oside resistance in endemic occurrence of Pseudomonas aeruginosa
3), http://dx.doi.org/10.1016/j.diagmicrobio.2013.09.015
Fig. 1. PFGE patterns and clusters. Clusters are shown in frames; the additional 3 isolates aligned to cluster B are framed with a dashed line. Arrows point to potential importation/
exportation events.
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5J. Mózes et al. / Diagnostic Microbiology and Infectious Disease xxx (2013) xxx–xxxOut of the 22 isolates found in 1 or 2 patients (small clusters and
unique patterns), 9 were susceptible to all antipseudomonas
antibiotics tested, and only 1 harboured aminoglycoside resistance
genes, an aac(6′)-Ib gene. (Other aminoglycoside resistance genes
were not detected in these 22 isolates.) A single isolate harboured an
empty integron (In0). Virulence gene distribution was very hetero-
geneous; only phzII, apr, exoT, and plcH genes were present in all
isolates; however, the other genes, except pilA and exoU, were found
in the majority (N16) of isolates. A single isolate harboured all 15
tested virulence determinants.
Out of the 39 patients, 24 had at least 1 isolate belonging to one of
the main clusters; all 24 were hospitalized in the ICU. Ten of the
remaining 18 patients (with isolates with unique patterns or
belonging to small clusters) were not admitted to the ICU. Ten
patients had more than 1 strain; these sometimes were carried
simultaneously, i.e., isolates belonging to the different strains were
isolated only 1 to 3 days apart. In returning patients, both main
clusters A and B harbouring class I integrons and aminoglycoside





























Antibiotic consumption of the pulmonology clinic between 2005
and 2009was above the university average (97.76 versus 38.78 DDDs/
100 bed-days); the most common antibiotics were macrolides,
amoxicillin + clavulanic acid, and ﬂuoroquinolones (average yearly
consumptions were 29.78, 26.58 and 16.56 DDDs/100 bed-days,
respectively). Aminoglycoside consumption similarly was above the
university average, 7.46 (5.79–9.90) versus 1.89 (1.91–2.51); beta-
lactam therapy was frequently potentiated by aminoglycosides.
Aminoglycosides used included streptomycin, netilmycin, tobramy-
cin, gentamicin, amikacin (average consumptions 0.26, 0.02, 1.42,
2.80, and 2.96 DDDs/100 bed-days). A switch from tobramycin to
gentamicin in 2006–2007 and then partial replacement of gentamicin
by amikacin in 2008–2009were observed. Fluoroquinolone usagewas
relatively frequent, 16.58 (12.3–20.7) DDDs/100 bed-days by average,
but a marked decrease and the lowest value were observed in 2009
(Fig. 2).
Out of the patients included in the study, only a single patient did
not receive any antibiotics. Broad-spectrum beta-lactams (piperacillin
+ tazobactam and carbapenems) were the most frequently adminis-
tered antibiotics. Amikacin was the most frequently used aminoglyco-
side; 19 of the 37 patients, i.e., 16 of the 28 ICU and 3 of the 11 non-ICU
patients (one of them for multidrug-resistant tuberculosis) received
amikacin (Table 1). Gentamicin was given to 3 patients only;
streptomycin, only to the tuberculotic patient; and 1 patient received
inhalational tobramycin. Other aminoglycosides were not used.Fig. 2. Aminoglycoside and ﬂuoroquinolone consumption rates of the Department of
Pulmonology.
Please cite this article as: Mózes J, et al, A potential role of aminoglyc
strains in lower airways of mechanic..., Diagn Microbiol Infect Dis (201Statistical analysis demonstrated that patients harbouring isolates
belonging to cluster A received signiﬁcantly more amikacin than
patients harbouring isolates from other clusters or with unique
ﬁngerprints (P = 0.046). As overall antibiotic consumptions (as well
as consumption of beta-lactams and ﬂuoroquinolones) were compa-



















Pattern of isolations and presence of P. aeruginosa strains for
months suggest an endemic occurrence of clusters A and B, which
were transmitted between multiple patients, recolonized returning
patients, and persisted for the whole study period. Disappearance of
any of the strains from the ICU was not conﬁrmed during the study
period. The majority of the ICU isolates (74/87) belonged to clusters A
and B, which were present throughout the study period; isolates of
cluster Cwere found less frequently but continuously. Transmission of
strains between the ICU and other wards was also detected, but most
non-ICU isolates showed unique patterns and were not clonal.
Similar endemic P. aeruginosa epidemiology was reported by Foca
et al. (2000) in a neonatal intensive care unit, where the source was
the healthcare personnel, and patients hospitalized for prolonged
periods served as a putative reservoir. Similar ﬁndings were reported
by Bergmans et al. (1998) and Suarez et al. (2011) in case of adult
patients. As the environment repeatedly proved to be negative for P.
aeruginosa, the reservoir of the strains must have been the healthcare
personnel or the patients (e.g., patients KI and SzG for cluster A in
January-February 2010 or patient KI for cluster B in the same period)
in the present study as well. Cross-transmission between patients was
reported to be the major route for colonization earlier (Bergmans
et al., 1998; Boyer et al., 2011).
It is also interesting that P. aeruginosa isolates of the same patient
isolated a few days apart were found to be genetically distinct. This
may be explained by the simultaneous colonization by multiple
strains (Ortega et al., 2004; Pirnay et al., 2003). Unfortunately, the
proportion of patients colonized with multiple strains at the same
time could not be assessed from the data in the present study. As
routine susceptibility testing is based on a single colony of a
homogeneous culture of a species, the possibility of simultaneous
presence of multiple strains, possibly with different susceptibilities,
must be acknowledged and considered by clinicians in treatment
decisions. The impact of colonization with multiple strains on
outcome is to be examined by upcoming studies.
Virulence pattern of the isolates was curious; it was not
unequivocal that a successful strain (i.e., one that is present in
multiple patients for prolonged periods) carries more virulence
factors than sporadic isolates (isolated from only 1 or 2 samples of
1 or 2 patients), as could be expected. For example, both frequently
isolated strains carried the gene exoS coding for a type 3 secretion
system effector shown to be important for VAP pathogenesis (Berra
et al., 2010), but not exoU, which is considered the most harmful
effector for host cells (Berra et al., 2010; Veesenmeyer et al., 2009). In
contrast, some sporadic isolates did carry exoU. Moreover, a sporadic
isolate with a wider array of virulence factors than that of the endemic
strains was also found. Though presence of a virulence gene is not
necessarily equal to its expression in efﬁcient amounts, present data
suggest that virulence patterns are not in direct association with
success as a colonizer or pathogen. Though one could argue that
ﬁndings on colonizing isolates are not necessarily applicable to
pathogenic isolates, it should also be considered that high mortality
was reported in heavily colonized ventilated patients without
clinically proven VAP (Zhuo et al., 2008).
Integron carriage is strongly associated with aminoglycoside





















































































































































6 J. Mózes et al. / Diagnostic Microbiology and Infectious Disease xxx (2013) xxx–xxxthe present study carrying a modifying enzyme gene tested was also
class I integron positive.
Both of the 2 most prevalent clones carried integrons and integron-
borne aminoglycoside resistance genes, but only 1 of 21 isolates not
belonging to major clusters carried an integron, which, in turn, did not
harbour any gene cassettes. High variability was observed regarding
resistance to beta-lactam agents among isolates of clusters A and B;
only aminoglycoside and ciproﬂoxacin resistance was common to all
isolates. A probable explanation may be a synergistic effect of the
integron-borne blaPSE-1 cassette and a putatively overexpressed efﬂux
pump (cluster A) as reported by Peña et al. (2009) or overexpression of
both the chromosomal ampC lactamase and efﬂux pumps (cluster B) as
reported by Deplano et al. (2005). Though in many reports the
suspicion of clonal spread is raised by a particular resistance pattern
shared by the isolates (Hsueh et al., 2005; Lolans et al., 2005), these
data show that isolates may be related even when this is not seen. In
such situations, an epidemiologically important strain may not be
identiﬁed, underlining the importance of surveillance studies in
settings where P. aeruginosa is a frequent pathogen.
The association between aminoglycoside resistance and clonality
suggests a role of aminoglycosides in the maintenance and/or spread
of successful clones. The pattern of antibiotic consumption, i.e.,
steadily increasing amikacin usage in the clinic and the statistically
signiﬁcant association of amikacin administration and carriage of
cluster A by the same patients points to the role of amikacin usage in
the emergence and maintenance of cluster A with integron-borne
resistance against amikacin and tobramycin. The role of antibiotic
consumption in provocation of resistance is well-known (Hsueh et al.,
2005; Iosiﬁdis et al., 2008; Loefﬂer et al., 2003), and it was reported as
a driving force for outbreaks as well (Falagas and Kopterides, 2006;
Suarez et al., 2011). In accordance with the above assumption,
antibiotic usage was shown to be a risk factor for cross-transmission
in case of P. aeruginosa as well (Boyer et al., 2011).
The present report shows a complex dynamics of P. aeruginosa,
characterized by continuous presence of at least 2 genetically
unrelated clones suggesting intensive transmission, which were
carrying aminoglycoside resistance genes on class I integrons in an
endemic epidemiological situation. The data collected indicate that
antibiotic usage may also be and sometimes may be the main driving
force for maintenance of not only outbreaks but endemic strains as
well. Antibiotic resistance in certain situations may be more
important than virulence in spread of successful clones.
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